1. New paradigms in clonal evolution: punctuated equilibrium in cancer
   William CH Cross et al, 2016, The Journal of Pathology CrossRef
2. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing–based cohort study
   Mayank Jauhri et al, 2017, Tumor Biology CrossRef
3. Drug Resistance Against Tyrosine Kinase Inhibitor in Gastrointestinal Malignancies
   L. V. K. S. Bhaskar et al, 2018, Role of Tyrosine Kinases in Gastrointestinal Malignancies CrossRef
4. Progression inference for somatic mutations in cancer
   Leif E. Peterson et al, 2017, Heliyon CrossRef
5. KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics
   Ioannis A. Voutsadakis, 2023, Critical Reviews in Oncology/Hematology CrossRef
6. PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis
   Juan Jin et al, 2020, Acta Oncologica CrossRef
7. KRAS, NRAS, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania
   Costel Stelian Brinzan et al, 2022, Medicine CrossRef
8. Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing
   Duarte Mendes Oliveira et al, 2018, Oncotarget CrossRef
9. Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer
   Chengfeng Wang et al, 2022, Journal of Clinical Laboratory Analysis CrossRef